M

Mark W. Dewhirst

Duke Medical Center

ORCID: 0000-0003-3459-6546

Publishes on Cancer, Hypoxia, and Metabolism, Ultrasound and Hyperthermia Applications, Nanoplatforms for cancer theranostics. 1k papers and 61.4k citations.

PubIndex Score77Top 23% · seniorHow it's scored

1kPublications

61.4kTotal Citations

First publication: 1984First senior author: 1989

Cancer, Hypoxia, and Metabolism Ultrasound and Hyperthermia Applications Nanoplatforms for cancer theranostics Angiogenesis and VEGF in Cancer Medical Imaging Techniques and Applications

Top publicationsby citations

Tumor Vascular Permeability, Accumulation, and Penetration of Macromolecular Drug Carriers

Matthew R. Dreher, Ashutosh Chilkoti, Mark W. Dewhirst et al.|JNCI Journal of the National Cancer Institute|2006

Cited by 923

Overcoming Limitations in Nanoparticle Drug Delivery: Triggered, Intravascular Release to Improve Drug Penetration into Tumors

Ashley A. Manzoor, Mark W. Dewhirst, Chelsea D. Landon et al.|Cancer Research|2012

Cited by 455

Drug targeting using thermally responsive polymers and local hyperthermia

Dan E. Meyer, Ashutosh Chilkoti, Byung-Cheol Shin et al.|Journal of Controlled Release|2001

Cited by 410

ERRα-Regulated Lactate Metabolism Contributes to Resistance to Targeted Therapies in Breast Cancer

Sung Hee Park, Donald P. McDonnell, Jason W. Locasale et al.|Cell Reports|2016

Cited by 141

Effect of Pazopanib on Tumor Microenvironment and Liposome Delivery

Tina D. Tailor, Mark W. Dewhirst|Molecular Cancer Therapeutics|2010

Cited by 107